American Century Companies Inc. Acquires 967,534 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)

American Century Companies Inc. lifted its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 223.9% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,399,756 shares of the company’s stock after purchasing an additional 967,534 shares during the period. American Century Companies Inc. owned 1.10% of Surgery Partners worth $29,633,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in SGRY. FMR LLC lifted its stake in Surgery Partners by 3.1% in the third quarter. FMR LLC now owns 18,311,867 shares of the company’s stock valued at $590,375,000 after buying an additional 546,869 shares during the period. Janus Henderson Group PLC raised its position in shares of Surgery Partners by 27.5% in the 3rd quarter. Janus Henderson Group PLC now owns 5,497,368 shares of the company’s stock valued at $177,235,000 after acquiring an additional 1,184,450 shares during the period. Geode Capital Management LLC raised its position in shares of Surgery Partners by 2.4% in the 3rd quarter. Geode Capital Management LLC now owns 1,864,346 shares of the company’s stock valued at $60,117,000 after acquiring an additional 42,897 shares during the period. King Street Capital Management L.P. bought a new position in Surgery Partners during the 3rd quarter worth approximately $46,748,000. Finally, E. Ohman J or Asset Management AB grew its holdings in Surgery Partners by 40.3% during the fourth quarter. E. Ohman J or Asset Management AB now owns 1,243,111 shares of the company’s stock valued at $26,317,000 after purchasing an additional 357,023 shares during the period.

Analysts Set New Price Targets

Several research firms have weighed in on SGRY. Bank of America initiated coverage on shares of Surgery Partners in a report on Monday, December 16th. They issued a “buy” rating and a $30.00 target price on the stock. JPMorgan Chase & Co. reduced their target price on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a report on Tuesday, December 3rd. Macquarie lowered their price target on Surgery Partners from $34.00 to $33.00 and set an “outperform” rating for the company in a report on Tuesday, March 11th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $35.00 price target on shares of Surgery Partners in a research report on Tuesday. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, Surgery Partners presently has an average rating of “Moderate Buy” and a consensus target price of $36.63.

Surgery Partners Stock Performance

Shares of Surgery Partners stock opened at $23.95 on Friday. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The firm has a market cap of $3.06 billion, a price-to-earnings ratio of -49.90, a price-to-earnings-growth ratio of 19.21 and a beta of 2.73. The stock’s 50-day moving average is $24.31 and its 200-day moving average is $25.59. Surgery Partners, Inc. has a one year low of $19.50 and a one year high of $33.97.

Surgery Partners (NASDAQ:SGRY) last released its earnings results on Monday, March 3rd. The company reported $0.39 EPS for the quarter, beating the consensus estimate of $0.38 by $0.01. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The firm had revenue of $864.40 million for the quarter, compared to analysts’ expectations of $828.09 million. Equities analysts predict that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Insider Activity at Surgery Partners

In other news, CEO Jason Eric Evans sold 26,520 shares of the stock in a transaction dated Friday, February 7th. The shares were sold at an average price of $25.65, for a total transaction of $680,238.00. Following the completion of the transaction, the chief executive officer now directly owns 560,698 shares in the company, valued at $14,381,903.70. This represents a 4.52 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Harrison R. Bane sold 56,315 shares of the firm’s stock in a transaction dated Friday, February 7th. The shares were sold at an average price of $25.64, for a total value of $1,443,916.60. Following the completion of the transaction, the insider now owns 107,037 shares of the company’s stock, valued at $2,744,428.68. The trade was a 34.47 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 106,622 shares of company stock valued at $2,717,860. Corporate insiders own 2.30% of the company’s stock.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.